Can a healthy 16‑year‑old receive Bexsero (meningococcal group B vaccine) and Menveo (quadrivalent meningococcal conjugate vaccine covering serogroups A, C, W‑135, Y) simultaneously?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Can a 16-Year-Old Receive Bexsero and Menveo Simultaneously?

Yes, a healthy 16-year-old can safely receive Bexsero (MenB-4C) and Menveo (MenACWY-CRM) at the same time. The FDA label explicitly states not to mix the vaccines in the same syringe, but concomitant administration at different injection sites is supported by both regulatory guidance and clinical evidence 1.

Regulatory and Guideline Support

The 2020 ACIP guidelines recommend that 16-year-olds receive:

  • MenACWY booster dose (if the first dose was given before age 16)
  • MenB series based on shared clinical decision-making, with preferred age 16-18 years 2

The FDA label for Menveo addresses concomitant administration directly, stating that while you cannot mix vaccines in the same syringe or vial, clinical trials have demonstrated safety and immunogenicity when Menveo was given concomitantly with other vaccines in adolescents 1.

Clinical Evidence

The highest quality recent evidence comes from a 2026 phase 3b randomized controlled trial (NCT04318548) specifically evaluating this exact scenario 3. This study enrolled 940 adolescents aged 16-18 years and demonstrated:

  • Non-inferiority was met for all co-primary endpoints: immune responses after concomitant administration were comparable to each vaccine given alone
  • Safety profile was comparable: reactogenicity of co-administration was similar to 4CMenB (Bexsero) administered alone
  • No immune interference between the two vaccines

Additional supporting evidence from a 2019 systematic review confirms that concomitant administration of meningococcal vaccines with other vaccines in adolescents generally does not affect immunogenicity, and while reactogenicity may increase slightly, no definitive safety concerns were identified 4.

Practical Administration

When administering both vaccines simultaneously:

  • Use separate injection sites (different limbs preferred)
  • Do not mix in the same syringe 1
  • Counsel about expected reactogenicity: local reactions (pain, swelling, erythema) and systemic symptoms (fatigue, headache, myalgia) are common with MenB vaccines and may be more noticeable with concomitant administration
  • Complete the MenB series: Bexsero requires 2 doses at least 1 month apart 2

Common Pitfalls to Avoid

  • Don't delay vaccination unnecessarily: waiting to separate vaccines by weeks or months provides no immunologic benefit and reduces the likelihood of series completion
  • Don't assume increased reactogenicity is a safety concern: while patients may experience more local reactions, this does not indicate harm and resolves without intervention
  • Don't forget the second MenB dose: ensure follow-up is scheduled for dose 2 of Bexsero (≥1 month after dose 1)

The evidence strongly supports simultaneous administration as both safe and effective, maximizing protection against invasive meningococcal disease while improving vaccination completion rates in this age group.

References

Related Questions

Can the meningococcal conjugate vaccine (Menveo) and the combined hepatitis A‑B vaccine (Twinrix) be administered together?
Can the human papillomavirus (HPV) vaccine, Menveo (meningococcal conjugate A/C/W/Y) vaccine, and Bexsero (meningococcal serogroup B) vaccine be administered simultaneously?
How can transmission of meningococcal meningitis from a child to household contacts be prevented?
What chemoprophylaxis regimen is appropriate for the asymptomatic household contacts of a pediatric patient diagnosed with meningococcal meningitis?
Which of the following statements about meningitis is false? A) A petechial rash may be observed in cases of meningococcal meningitis. B) Diagnosis is established via lumbar puncture and cerebrospinal fluid culture. C) Kernig's and Brudzinski's signs are characteristic clinical findings. D) There are no vaccines available for the prevention of meningitis. E) Headache, fever, and photophobia are frequently observed clinical signs.
What is the step-by-step detailed pathophysiology of post-hepatic (obstructive) jaundice?
What is the Bexsero (meningococcal serogroup B) vaccine?
What antibiotic regimen should be used for an otherwise healthy adult with community-acquired pneumonia, including options for penicillin allergy, recent antibiotic use, chronic lung disease, and renal impairment?
What is the appropriate management for a 37-year-old male with three days of right lower leg pain, erythema, and tenderness over the proximal medial aspect?
How should fetal hydrops of unknown etiology be evaluated and managed?
What is the appropriate management for a patient with an elevated white blood cell count (13.4 ×10⁹/L), negative duplex ultrasound for deep vein thrombosis, and a right knee X-ray showing cellulitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.